These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 12054513

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
    Yoshimura M, Sakamoto M, Ikemoto M, Mochizuki Y, Yuasa K, Miyagoe-Suzuki Y, Takeda S.
    Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
    Harper SQ, Hauser MA, DelloRusso C, Duan D, Crawford RW, Phelps SF, Harper HA, Robinson AS, Engelhardt JF, Brooks SV, Chamberlain JS.
    Nat Med; 2002 Mar; 8(3):253-61. PubMed ID: 11875496
    [Abstract] [Full Text] [Related]

  • 7. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
    Gardner KL, Kearney JA, Edwards JD, Rafael-Fortney JA.
    Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
    [Abstract] [Full Text] [Related]

  • 8. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
    Lochmüller H, Petrof BJ, Pari G, Larochelle N, Dodelet V, Wang Q, Allen C, Prescott S, Massie B, Nalbantoglu J, Karpati G.
    Gene Ther; 1996 Aug; 3(8):706-16. PubMed ID: 8854096
    [Abstract] [Full Text] [Related]

  • 9. The short MCK1350 promoter/enhancer allows for sufficient dystrophin expression in skeletal muscles of mdx mice.
    Larochelle N, Oualikene W, Dunant P, Massie B, Karpati G, Nalbantoglu J, Lochmuller H.
    Biochem Biophys Res Commun; 2002 Apr 05; 292(3):626-31. PubMed ID: 11922612
    [Abstract] [Full Text] [Related]

  • 10. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
    Bujold M, Caron N, Camiran G, Mukherjee S, Allen PD, Tremblay JP, Wang Y.
    Cell Transplant; 2002 Apr 05; 11(8):759-67. PubMed ID: 12588108
    [Abstract] [Full Text] [Related]

  • 11. [Development of new therapy on muscular dystrophy].
    Takeda S.
    Rinsho Shinkeigaku; 2001 Dec 05; 41(12):1154-6. PubMed ID: 12235824
    [Abstract] [Full Text] [Related]

  • 12. A canine minidystrophin is functional and therapeutic in mdx mice.
    Wang B, Li J, Qiao C, Chen C, Hu P, Zhu X, Zhou L, Bogan J, Kornegay J, Xiao X.
    Gene Ther; 2008 Aug 05; 15(15):1099-106. PubMed ID: 18432277
    [Abstract] [Full Text] [Related]

  • 13. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG, Wehling-Henricks M.
    Mol Genet Metab; 2004 Aug 05; 82(4):312-20. PubMed ID: 15308129
    [Abstract] [Full Text] [Related]

  • 14. [Adeno-associated virus vector carrying human minidystrophin gene SMCKA3999 effectively ameliorates dystrophic pathology in mdx model mice].
    Li HH, Zhang SM, Fang SY, Chen CL, Luo YD, Guan Y, Wang DW, Xiao X.
    Zhonghua Yi Xue Za Zhi; 2003 Sep 10; 83(17):1513-6. PubMed ID: 14521733
    [Abstract] [Full Text] [Related]

  • 15. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
    Smith J, Goldsmith C, Ward A, LeDieu R.
    Cell Death Differ; 2000 Nov 10; 7(11):1109-18. PubMed ID: 11139285
    [Abstract] [Full Text] [Related]

  • 16. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.
    Wehling M, Spencer MJ, Tidball JG.
    J Cell Biol; 2001 Oct 01; 155(1):123-31. PubMed ID: 11581289
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
    Cox GA, Cole NM, Matsumura K, Phelps SF, Hauschka SD, Campbell KP, Faulkner JA, Chamberlain JS.
    Nature; 1993 Aug 19; 364(6439):725-9. PubMed ID: 8355788
    [Abstract] [Full Text] [Related]

  • 18. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K, Kimura S, Ozasa S, Matsukura M, Ikezawa M, Yoshioka K, Ueno H, Suzuki M, Araki K, Yamamura K, Miwa T, Dickson G, Thomas GD, Miike T.
    Hum Mol Genet; 2006 Jul 15; 15(14):2266-75. PubMed ID: 16777842
    [Abstract] [Full Text] [Related]

  • 19. Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice.
    Fabb SA, Wells DJ, Serpente P, Dickson G.
    Hum Mol Genet; 2002 Apr 01; 11(7):733-41. PubMed ID: 11929846
    [Abstract] [Full Text] [Related]

  • 20. [Gene therapy for muscular dystrophy].
    Takeda S.
    No To Hattatsu; 2004 Mar 01; 36(2):117-23. PubMed ID: 15031985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.